Der Pharmahersteller Formycon DE000A1EWVY8 hat Patentstreitigkeiten zu seinem Eylea-Biosimilar FYB203 mit dem US-Unternehmen Regeneron Pharmaceuticals US75886F1075 beigelegt.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.